Skip to main content

Table 2 Baseline characteristics of 70 recurrent patients after RFA

From: Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation

Characteristics

RFA cohort

Age, yr, median, (range)

51.0 (31–79)

Gender (Female/Male)

13/57 (18.6%/81.4%)

Cirrhosis (yes/no)

57/13(81.4%/18.6%)

GGT, U/L, median (range)

53.5 (17.0–500.0)

ALT, U/L, median (range)

42.5 (9.0–499.0)

ALB, g/L, median (range)

45.0 (33.0–57.0)

TBIL, µmol/L, median (range)

12.6 (4.6–31.6)

AFP, ng/ml, median (range)

100.5 (1–60,500.0)

HBsAg (Positive/Negative)

59/11 (84.3%/15.7%)

Tumor number (single/multiple)

59/11 (84.3%/15.7%)

Tumor size (cm)

  ≤ 2

10 (14.3%)

  > 2, ≤ 3

23 (32.9%)

  > 3, ≤ 5

37 (52.8%)

BCLC stage (0/A)

7/63 (10.0%/90.0%)

  1. Abbreviations: RFA Radiofrequency ablation, GGT Gamma-glutamyl transpeptidase, ALB Albumin, TBIL Total bilirubin, AFP Alpha fetoprotein, HBsAg Hepatitis B virus surface antigen, BCLC Barcelona Clinic Liver Cancer